Background Currently 20-35% of pregnant women are obese, posing a major health risk for mother and fetus. It is postulated that an abnormal maternal-fetal nutritional environment leads to adverse metabolic programming, resulting in altered substrate metabolism in the offspring and predisposing to risks of obesity and diabetes later in life. Data indicate that oocytes from overweight animals have abnormal mitochondria. We hypothesized that maternal obesity is associated with altered mitochondrial function in healthy neonatal offspring. Methods Overweight and obese (body mass index, (BMI) ≥ 25 kg/m 2 , n = 14) and lean (BMI < 25 kg/m 2 , n = 8), African-American pregnant women carrying male fetuses were recruited from the Barnes Jewish Hospital obstetric clinic. Maternal and infant data were extracted from medical records. Infants underwent body composition testing in the first days of life. Circumcision skin was collected for isolation of fibroblasts. Fibroblast cells were evaluated for mitochondrial function, metabolic gene expression, nutrient uptake, and oxidative stress. Results Skin fibroblasts of infants born to overweight mothers had significantly higher mitochondrial respiration without a concurrent increase in ATP production, indicating mitochondrial inefficiency. These fibroblasts had higher levels of reactive oxygen species and evidence of oxidative stress. Evaluation of gene expression in offspring fibroblasts revealed altered expression of multiple genes involved in fatty acid and glucose metabolism and mitochondrial respiration in infants of overweight mothers. Conclusions This study demonstrates altered mitochondrial function and oxidative stress in skin fibroblasts of infants born to overweight mothers. Future studies are needed to determine the long-term impact of this finding on the metabolic health of these children.
Introduction
The obesity epidemic is a major public health concern; it is estimated that by the year 2025, 300 million people worldwide will have metabolic syndrome, with significant secondary health problems contributing to morbidity and mortality, affecting people of all ages [1] . Approximately 25-30% of pregnant women are overweight, defined as a body mass index (BMI) ≥ 25 kg/m 2 [2, 3] . Increased maternal weight prior and during pregnancy is associated with several complications, including cesarean delivery, fetal growth disorders, preeclampsia, still-birth, prematurity, and congenital anomalies [4] [5] [6] . Additionally, data show that offspring born to obese mothers are at a greater risk of development of obesity in childhood, adolescence, and adulthood [7] . Elevated prepregnancy BMI correlates positively with higher leptin, inflammatory markers, increased insulin resistance, and increased abdominal and hepatic lipid content in offspring [8] [9] [10] , indicating an impact of maternal nutritional status on the metabolic milieu of her offspring. The developmental origins of adult disease hypothesis suggests a suboptimal nutritional environment in utero, which includes starvation or over-nutrition, can increase susceptibility of the offspring to adult diseases, such as obesity, cardiovascular disease, or metabolic syndrome [11, 12] . This theory and the above mentioned observational data are supported by animal models. Studies done in rodents, sheep and non-human primates demonstrate that maternal over-nutrition has been associated with alterations in offspring body composition, such as increased fat mass and reduced muscle mass [13, 14] . These studies also suggest that maternal obesity is poorly correlated with birthweight and that offspring born to obese mothers can have diverse weight spectrum: growth-restricted, overweight, or normal birthweight [13] [14] [15] . Data show that a maternal obesogenic diet is associated with metabolic changes including higher glucose, insulin, leptin, and triglyceride levels and lower adiponectin secretion in the offspring [13] [14] [15] [16] . Evidence also suggests that suboptimal maternal nutrition can alter gene expression and enzyme function of the key regulators and mediators of metabolism [16] [17] [18] . Taken together, these data indicate an important impact of maternal obesity on the metabolic function of her offspring. It is proposed that these changes in offspring metabolism can subsequently lead to infant obesity and an increased risk for adult diseases [11, 13] . The exact mechanism of this developmental programming is not fully understood.
Mitochondria are at the center of energy metabolism, and are strongly implicated in the development of metabolic disease associated with maternal nutrition. Several investigations in mouse models of obesity and diabetes have demonstrated abnormal mitochondria in maternal oocytes [19] [20] [21] [22] [23] . Oocytes from mice fed with high fat diet showed signs of altered mitochondrial activity, such as reduced mitochondrial membrane potential and altered mitochondrial morphology on electron microscopy [20] [21] [22] . Oocytes of obese female mice had a higher mitochondrial DNA (mtDNA) content and increased expression of mitochondrial biogenesis markers [20, 23] . Recent data from mice with metabolic syndrome demonstrated that mitochondrial dysfunction associated with maternal obesity can be passed down to the second and third generation through the female germline [22] . One recent human study noted a correlation between maternal weight and infant size at birth, as well as between mtDNA and infant size at birth, indicating a possible impact of mitochondrial content in offspring metabolism [24] . However, despite the epidemiologic data in humans, there remains minimal data in human infants regarding cellular mitochondrial changes associated with maternal obesity.
We sought to evaluate metabolism and mitochondrial function in healthy human neonates. To our knowledge, ours is the first study to analyze the impact of maternal obesity during pregnancy on mitochondrial function in human offspring. In order to evaluate metabolism and mitochondrial function in human cells, we sought to obtain tissue from healthy neonates that would otherwise be discarded. To that end, this study focused on male infants with planned circumcision. We hypothesized that infants born to overweight mothers would have altered skin fibroblast mitochondrial function compared with infants born to lean mothers.
Methods

Study design
This prospective observational cohort study included mother-infant pairs who delivered at Barnes-Jewish Hospital in St. Louis, MO between August 2014 and June 2015. This study was an ancillary study to an existing study of overweight pregnant African-American women ("LIFE-MOMS", NCT101768793). Approval for this study was obtained from the Institutional Review Board at Washington University School of Medicine. Women were approached for enrollment with informed consent during a prenatal visit and consented if they met inclusion criteria, which included: maternal age between 18 and 35 years, singleton gestation less than 34 weeks at time of enrollment, normal fetal anatomy, and carrying a male fetus with plans for circumcision. Women were excluded for any of the following: baseline diabetes mellitus Types 1 and 2, congenital abnormalities, history of gestational diabetes, active substance abuse, or treatment with medications known to impact metabolism or body weight. Maternal demographic and clinical data were extracted from the electronic medical records (including age, prepregnancy BMI-defined based on self-reported weight at first prenatal visit), gestational weight gain (GWG-determined as difference between prepregnancy weight and weight at delivery), mode of delivery, pregnancy complications, and socioeconomic status). Gestational age (GA) was confirmed by first trimester ultrasound. Expecting mothers were categorized as lean (BMI < 25 kg/m 2 ) or overweight/obese (BMI ≥ 25 kg/ m 2 ). Overweight mothers did not have gestational diabetes. Women had a visit to the Clinical Research Unit (CRU) at Washington University between 32 and 34 weeks gestation to have their body fat percentage estimated via skinfold measurement [25, 26] and fasting blood work that included: high-density lipoprotein, low-density lipoprotein, total cholesterol, glucose, and insulin.
Infant demographic and clinical data were extracted from the chart following the delivery (including GA, APGAR scores, birthweight, length and head circumference, and delivery complications). Newborns underwent a visit in the CRU between 24 and 72 h of life for body composition, measured by Peapod (Cosmed USA Inc.) and for the measurement of resting metabolic rate via indirect calorimetry, skinfold testing, and standard length and height. At the time of circumcision, which was done 18-72 h after birth, skin was collected in culture media for isolation of fibroblasts.
Isolation and culture of skin fibroblasts
Skin fibroblasts were isolated by the Genome Engineering & Induced Pluripotent Stem Cell Center at Washington University School of Medicine. Cells were received frozen at passage 3. Fibroblasts were cultured in alpha minimal essential media (MEM) (Gibco) supplemented with 50 ml FBS, 1 ml penicillin/streptomycin (1%), and 2 ml L-glutamine (0.4%) and incubated at 37°C in 5% CO 2 atmosphere. All analyses described throughout this study were carried out at passages 4-7.
Mitochondrial function testing
Fibroblasts were grown in T75 flasks to 70-80% confluence, and then gently detached by trypsinization, washed in phosphate-buffered saline (PBS) and counted. Oxygen consumption rate (OCR) was measured in adherent fibroblasts with a XF96 Extracellular Flux Analyzer (Agilent Technologies). Each cell line was seeded in eight wells of a 96-well plate at a density of 4 × 10 3 cells/well in 80 µl of alpha MEM and incubated for 12-18 h at 37°C in 5% CO 2 atmosphere. After replacing the growth medium with unbuffered dulbecco modified eagle medium (pH 7.4, 1000 mg/l glucose) supplemented with 1 mM pyruvate and 10 mM D-glucose, cells were incubated for 30-60 min in a CO 2 free incubator. Baseline measurements of OCR were determined, followed by the addition of oligomycin (1 µM), FCCP (carbonilcyanide p-triflouromethoxyphenylhydrazone 1 µM), and antimycin/rotenton (1 µM combined). Determinations of baseline, maximal respiratory rate, ATP production, and spare capacity were made as previously described [27] .
RNA extraction and quantitative real-time PCR
Fibroblasts were rinsed in PBS and homogenized in TRIzol reagent (Invitrogen), followed by subsequent RNA isolation as per manufacturer's instructions. RNA was quantified and used to generate cDNA via the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Synthesized cDNA was used for quantitative PCR (qPCR) using SYBR Green (Applied Biosystems) with appropriate primers, and performed in triplicate on a Stratagene Mx3005P qPCR machine, as previously described [28] . Relative quantification after normalization to 36B4 expression was calculated using the 2 − ΔCT formula. Primer sequences are available upon request.
Mitochondrial superoxide staining
Fibroblasts were plated in a six-well plate at 300,000 cells per well. After incubation for 24 h, cells were loaded with 1 ml of 5 μM MitoSOX Red (Invitrogen) and incubated for 10 min at 37°C in 5% CO 2 atmosphere. Cells were washed three times with Hank's balanced salt solution with calcium and magnesium (Gibco), trypsinized and placed in alpha MEM. Using a flow cytometer (FlowJo, LLC), MitoSOX Red was excited at 488 nm and fluorescence emission at 575 was measured. Fluorescence was quantified using fluorescence-activated cell sorting.
Western blotting
Fibroblast lysates were created using RIPA buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, and 0.1% SDS) with EDTA-Free protease complete tablet (Roche), PMSF, and 2% 2mercaptoethanol. A total of 20 μg of protein per sample was loaded onto 10% SDS PAGE gels. Carbonylated proteins were detected using the Oxyblot Protein Oxidation Detection Kit (EMD Millipore) as per the manufacturer's instructions. Blots were visualized and bands quantified using the LI-COR Odyssey imaging system. Actin was used as the loading control.
Statistical analysis
All statistical analyses were performed using the IBM-SPSS (Statistical package for Social Science) software package. Overweight and lean subjects were compared with descriptive and bivariate statistics using Mann-Whitney Utest for continuous variables with equal variance, Kolmogorov-Smirnov test for continuous variables with unequal variance (only maternal weight and body fat), and Fisher's exact test for categorical variables. Continuous variables are reported as median and interquartile range (IQR), categorical variables are presented as N (%). Spearman correlations were run between the outcome variables (basal respiration, maximal respiration, ATP production and spare capacity) and variables-of-interest (maternal weight, prepregnancy BMI, maternal body fat percent, infant body fat percent). Spearman correlations were then run between the outcome variables and all other variables in the dataset. Due to the small sample size, we were only able to include two additional variables for the regression analysis. Therefore, regression models were performed by including the outcome variable with the highest correlation and two of the variables with the highest correlation. P-values were not adjusted for multiple comparisons.
Results
Maternal characteristics
We initially enrolled 40 African-American women carrying male fetuses (17 lean controls, 23 overweight). One woman voluntarily withdrew, one woman delivered at an outside facility and we were unable to obtain circumcision skin or collect maternal/infant metabolic data for 16 patients. We performed complete analysis on the remaining 22 subjects (8 lean, 14 overweight). The maternal pregnancy demographics are displayed in Table 1 . Other than maternal weight, BMI, and body fat percent, there were no significant differences between maternal characteristics. Pre-pregnancy BMI in the lean group ranged from 18 to 25 kg/m 2 , and the overweight group ranged from 25 to 39.6 kg/m 2 . The lean group had a median body fat percent of only 19%. Only one woman in our control group (12.5%) and one woman in our overweight cohort (7.1%) achieved their target weight based on their pre-gestational BMI. While there was no statistically significant difference in GWG between groups, the overweight mothers did have a greater total weight gain during pregnancy, and a greater percent of overweight mothers were above their target weight gain (Table 1) . Most women were in their 20s, and all infants delivered at term. All (100%) lean mothers delivered vaginally, whereas a majority (57.1%) of overweight mothers delivered by cesarean section. Most common reasons for cesarean section was non-reassuring fetal status (50%) followed by repeat cesarean section (37.5%). There were no significant differences in maternal glucose or insulin levels measured during the third trimester CRU visit (32-34 weeks).
Infant characteristics
Infants born to overweight mothers had a greater length at birth when corrected for GA: 52nd percentile, (IQR 51st-63.5th) vs. 95th percentile (IQR 80th-100th) with zscores of 0.05 (IQR 0.028-0.46) vs. 1.8 (IQR 0.84-2.7), p < 0.01). There was no significant difference in birthweight between both the groups when birthweight was corrected for height and GA. However, head circumference, corrected for GA was also significantly higher in infants of overweight mothers ( Fig. 1a-d ). Weight and body composition were assessed at 24-72 h postpartum using Peapod. Infants born to overweight mothers had significantly higher weights at this point compared with their lean counterparts (data not shown, 2963 g (IQR 2463-3440) vs. 3446 g (IQR 3131-3773), p = 0.046). This difference in weight was not significant when corrected for GA (data not shown). Although total body fat and body fat percent tended to be greater in infants born to overweight mothers, this did not reach statistical significance (Fig. 1e, f) . We also performed indirect calorimetry to evaluate and compare the infants' metabolic rate; there were no significant differences in oxygen consumption, resting energy expenditure (RER), and respiratory quotient between infants born to lean vs. overweight mothers (Supplemental data). Majority of infants in both groups were breast fed; 62.5% in the control group and 42.9% in the overweight group. One infant in the overweight group received D10 intravenous fluids for 24 h. The indirect calorimetry testing for this infant was performed when he was off intravenous fluids and breast and bottle feeding for >24 h. In order to determine whether there were baseline differences in circulating metabolites or insulin levels in these infants, we measured glucose, free fatty acids (FAs), triglycerides, cholesterols, insulin, and cpeptide from cord blood. While there was no significant differences in free FA, triglycerides, cholesterols, (data not shown) or glucose levels (Fig. 1g) , insulin was significantly elevated in infants born to overweight mothers (Fig. 1h, 4 
Metabolic function in skin fibroblasts
In order to evaluate cellular nutrient uptake, we evaluated glucose and FA uptake in a subset of fibroblasts from infants born to lean and overweight mothers. There was no significant difference in glucose or FA uptake among fibroblasts of infants born to lean mothers compared with the overweight cohort (data not shown). We next evaluated mitochondrial function in the skin fibroblasts. Figure 2 shows that skin fibroblasts of infants born to overweight mothers had significant differences when compared with skin fibroblasts from infants born to lean mothers, including higher maximal respiration (Fig. 2b, 89 .0 pmol/min (IQR 61.2-113.5) vs. 122.0 pmol/min (IQR 100.4-138.5), p = 0.01), a higher spare respiratory capacity (Fig. 2d, 44 .6 pmol/min (IQR 28.0-61.3) vs. 67.8 pmol/min (IQR 58.3-77.6), p < 0.01), and a trend toward significantly higher basal respiration ( Fig. 2a, 44 .3 pmol/min (IQR 34.5-53.0) vs. 54.2 pmol/min (IQR 49.8-59.5), p = 0.06). Interestingly, there was no difference in ATP production ( Fig. 2c, 40 .2 pmol/min (IQR 30.9-48.8) vs. 46.3 (IQR 44.0-53.6) in the infant skin fibroblasts from overweight mothers compared with lean mothers, suggesting that these mitochondria work inefficiently. Supporting this theory, we found a trend toward a higher proton leak in the fibroblasts of infants born to overweight mothers compared with the lean cohort (lean-4.3 pmol/min (IQR 3.5-5.0) vs. OW-5.5 pmol/min (IQR 4.4-6.8), p = 0.1).
In order to further understand the association between maternal weight and body fat on infant mitochondrial function, we performed correlation analyses. We noted that maternal prepregnancy weight had a significant association with maximal respiration and spare respiratory capacity (Fig. 3a,b) . These associations remained significant after controlling maternal age and maternal triglyceride levels. We also noted significant correlations between maternal prepregnancy BMI and maternal body fat percentage and respiration ( Fig. 3c-f ), although the correlation was less significant than the prepregnancy weight. GWG was not significantly correlated with respiration rates. There were also no significant correlations between maternal glucose and insulin levels and infant glucose, insulin, or mitochondrial respiration rates.
Metabolic gene expression and mtDNA quantification
Given the differences in mitochondrial function, we sought to determine whether there were differences in gene expression for genes involved in metabolism and mitochondrial function. We performed quantitative real-time PCR for selected target genes involved in metabolic and mitochondrial function. Figure 4 demonstrates that there are several alterations in gene expression. Sterol regulatory element-binding protein 1 (SREBP1c) is a transcriptional regulator of several genes involved in glucose metabolism and FA and lipid production, and its expression is regulated by insulin [29] . SREBP1c and upstream stimulatory factors 1 and 2 transcriptionally regulate FA synthase (FAS). Both SREBP1c and FAS were higher in fibroblasts from infants born to overweight mothers. Solute carrier family 2 member 1 (SLC2a1) is involved in glucose transport and metabolism, and it was lower in the fibroblasts of the overweight group. ATP synthase 5a, which converts ADP to ATP in the mitochondria, was upregulated in the fibroblasts of the overweight group compared with the lean group. Hexokinase 2, the first enzyme in glucose metabolism, was unchanged. Interestingly, compared to the lean cohort, Fig. 2 Increased fibroblast mitochondrial function in infants born to overweight mothers. Oxygen consumption at baseline (basal, a) after adding oligomycin (ATP production, d) and FCCP (maximal, b). Spare capacity (c) represents the difference between maximal and basal oxygen consumption rate (OCR). Data displayed as boxand-whisker plots with line at the median. (lean, n = 8, overweight (OW), n = 14)) *p < 0.05 uncoupling protein 2 mRNA was significantly more expressed in fibroblasts of infants born to overweight mothers. There was no difference in mtDNA quantity in fibroblasts from infants of lean mothers compared to overweight mothers.
Oxidative stress
Given the increase in uncoupling Protein 2 and the increased oxygen consumption without increase in ATP production, we were interested in the potential for the increased production of reactive oxygen species (ROS). We first performed cellular staining in a subset of our fibroblast samples using MitoSox, which stains mitochondrial superoxide and noted a higher total number of fluorescent cells (Fig. 5a, left) and significantly increased the median fluorescence intensity in fibroblasts of infants born to overweight mothers compared with infants born to lean mothers (Fig. 5a, right) . Given this evidence of increased superoxide in the skin fibroblasts of infants born to overweight mothers, we explored the possibility of oxidative protein damage in these cells. To that end, we performed western blotting to detect protein carbonylation using the Oxyblot kit. Protein carbonylation was higher in skin fibroblasts from infants born to overweight mothers compared with infants born to lean mothers (Fig. 5b) .
Discussions
Evidence indicates that maternal obesity alters oocyte and offspring mitochondrial function [20, 22, 23] , but the impact of maternal obesity on mitochondrial function in human neonates is unknown. As an initial step to answer this question, we evaluated the mitochondrial function in skin fibroblasts of healthy neonates born to either overweight or lean mothers. To our knowledge, this is the first study to show that mitochondrial function is altered in human infants born to overweight mothers. We demonstrate that skin fibroblasts in infants born to overweight mothers have increased mitochondrial respiration without a significant increase in ATP production, indicating inefficient respiration. Given the correlation between maternal weight, prepregnancy BMI and maximal OCRs, this increase in mitochondrial respiration appears related to maternal prepregnancy nutrition status. Although, the higher frequency of women that were above their target weight in the overweight group, does make it more difficult to be certain that only prepregnancy nutrition status impacts the mitochondria. Previous animal models have shown damaged mitochondria and decreased mitochondrial function in oocytes of obese mothers [20, 23] . Additionally, Saben et al. [22] found decreased mitochondrial function in the skeletal muscle of F1 offspring of mothers who were fed a high fat/ high sugar diet. It is possible that we found increased mitochondrial function, as a result of a compensatory response to inheritance of damaged maternal mitochondria. Previous studies have also demonstrated that oxidative stress can drive mitochondrial biogenesis (Igosheva, Lee HC 2000 [23] ). Thus, one might consider that an increase in mitochondrial mass might drive increased respiration. While we did not note a difference in mtDNA quantity or transcriptional regulators of mitochondrial biogenesis (data not shown), it is still reasonable to consider that maternal oxidative stress might impact offspring respiration rates.
We were able to detect these differences in mitochondrial metabolism in tissue with relatively low metabolic rate. One could speculate that differences maybe even more evident in tissues with higher metabolic rates, such as myocardial or brain tissue. However, we cannot be certain that these specific mitochondrial function differences will exist in all tissues. The lack of difference in RER or oxygen consumption by indirect calorimetry, despite finding differences in fibroblast oxygen consumption, is likely related to variability in measurements in neonates, particularly related to technical aspects of the study and standardization of feeding. A future study to evaluate these parameters in older infants would be ideal. The lack of increase in ATP production suggests more uncoupled respiration, which was also noted by Saben et al. [22] , as they noted reduced respiratory control ratio in offspring of mice with metabolic syndrome. Previous work in murine models of obesity and diabetes noted a progression from normal to decreased mitochondrial function in insulin resistant to frank diabetic heart muscle [30] . This study also noted inefficient respiration in the earlier insulin resistant animals. Given that we studied early neonates, and the previous offspring data was in 8 week-old animals, we speculate that there may be an early compensatory response that later leads to decreased mitochondrial function.
The potential for increased uncoupled respiration is supported by the robust increase in UCP2 mRNA expression and the trend toward increased proton leak in skin fibroblasts of neonates born to overweight mothers compared with lean mothers. The family of uncoupling proteins extrude protons from the intermembrane space into the mitochondrial matrix, thus dissipating the proton gradient and decreasing ATP and superoxide production [31, 32] . Thus, increased UCP2 expression is considered an adaptive response to attenuate mitochondrial ROS production and protect against oxidative damage [33, 34] . Evidence suggests that metabolic diseases, such as obesity or diabetes, are associated with elevated ROS levels and therefore elevated oxidative stress [35, 36] . Data also show that increased ROS production, specifically superoxide radicals, [37] . Consistent with these findings, we detected an increase in superoxide molecules in the skin fibroblasts of infants born to overweight mothers. This increase in superoxide may be driving the increase in UCP2 expression as an adaptive mechanism to protect the mitochondria against oxidative damage. Previous studies have shown that overproduction of ROS is associated with oxidative damage to proteins, lipids, and DNA [38] , which we detected as increased protein carbonylation in the skin fibroblasts. Moreover, accumulation of ROS can lead to mtDNA damage, which contributes to abnormal electron transport chain function and compromises cell viability. This can eventually result in apoptotic cell death [39] [40] [41] . We postulate, that this progression in mitochondrial dysfunction in the setting of oxidative stress might be the reason why our study found increased mitochondrial function in these early neonates, whereas Saben et al. detected decreased mitochondrial function in older animals.
In addition to altered mitochondrial oxygen consumption, we noted significant changes in metabolic gene expression, as well as cord blood insulin in infants born to overweight mothers. Many of the gene changes we noted are consistent with previous findings. Upregulation of genes involved in lipid and mitochondrial metabolism was previously demonstrated in human umbilical vein endothelial cells of infants born to obese mothers [42] . Long et al. [43] demonstrated greater mRNA expression for FAS in adipose depots of offspring from obese ewes. Additionally, SREBP1c, a transcriptional regulator involved in FA metabolism, is known to be activated in the setting of overnutrition, resulting in accumulation of FAs and secondarily, insulin resistance [44, 45] . While we did not see a difference in FA uptake in our cells, we did see upregulation of both SREBP1c and FAS. Evidence suggests that diabetic rats have a decreased expression of GLUT1, also known as SLC2a1 [46] . The increased expression of enzymes mediating FA biosynthesis along with a decrease in glucose transporters may represent an adaptation to altered nutrient availability associated with obese pregnancy. ATP synthase is a central enzyme that converts ADP to ATP. Data suggests that obesity and diabetes is associated with an upregulation of enzymes involved in oxidative phosphorylation [47] . We suspect that this increase in ATP synthase might be a compensatory response to the inefficient mitochondria. The mechanism leading to the altered gene expression is not clear. There is strong evidence demonstrating that shortterm exposure to hyperinsulinemia in healthy subjects results in increased mRNA expression for several inflammatory genes and transcription factors in human muscle biopsies [48, 49] . It is interesting that maternal insulin levels were not different between the groups, yet we detected a significant increase in insulin in the cord blood of the offspring from overweight mothers. This suggests evidence of early insulin resistance, which may be related to the early mitochondrial dysfunction. It is unclear at this point whether elevated insulin levels and altered nutrient availability during development cause modified gene expression, or whether this could be due to a programming effect, such as epigenetic changes. Future studies should focus on small RNA expression, histone modification, or DNA methylation as a mechanism for driving gene expression and metabolic changes in infants born to overweight mothers.
Our study has several limitations. The small sample size may limit the power to detect differences, and potentially limits the generalizability of our findings. We only enrolled male neonates; a future aim will be to investigate whether umbilical cells can be used in a similar manner to evaluate mitochondrial function in all neonates. We also only enrolled African-American mothers. African-Americans have a higher incidence of obesity [50, 51] , and are at a higher risk of developing oxidative stress-related diseases, such as Type 2 diabetes [52] , thus our results are very relevant for this population. However, it is possible that our results cannot be generalized to other races. To our knowledge, there is no current data regarding ethnic differences in mitochondrial function. Additionally, the overweight group had a higher rate of cesarean delivery, which may have impacted the metabolic response in the offsprings. Enrolling a heterogenous group of both overweight and obese females may limit our ability to detect smaller differences between our lean and overweight cohort. Using skin fibroblasts to assess global mitochondrial activity has not been validated, but skin biopsies are one method for diagnosing mitochondrial diseases [53] . It is unclear whether our findings could be applied to other cells in these infants. Since mitochondria are maternally inherited and our findings are in skin fibroblasts at a very young age, it is suggestive of a global process.
Conclusions
This prospective study in healthy human neonates demonstrates altered mitochondrial function and oxidative stress in skin fibroblasts of infants born to overweight mothers. Future studies are needed to determine the long-term impact of this finding on the metabolic health of these children. In particular, it will be important to determine if early mitochondrial function can predict later body composition, and whether mitochondrial function changes over time.
